Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

198
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
198
Structure of Cadherins01:25

Structure of Cadherins

3.4K
The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins”   is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...
3.4K
The Nucleolus02:55

The Nucleolus

8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Nucleic Acid Structure01:25

Nucleic Acid Structure

6.2K
The pentose sugar in DNA is deoxyribose, while in RNA the pentose sugar is ribose. The difference between the sugars is the presence of the hydroxyl group on the ribose's second carbon and a hydrogen on the deoxyribose's second carbon. The phosphate residue attaches to the hydroxyl group of the 5′ carbon of one sugar and the hydroxyl group of the 3′ carbon of the sugar of the next nucleotide, which forms  a 5′ to 3′ phosphodiester linkage.
DNA Structure
DNA...
6.2K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

242
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
242

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A peroxisomal metabolic route from benzoyl-CoA to benzyl alcohol for phenylalanine-derived salicylic acid biosynthesis in rice.

Molecular plant·2026
Same author

Asthma increased the risk of atrial fibrillation: insights from clinical association to genetic and molecular evidence.

BMC pulmonary medicine·2026
Same author

Establishment and Parameter Calibration of a Discrete Element Model for Shanghai Bok Choy Plug Seedling.

Plants (Basel, Switzerland)·2026
Same author

Rational design, molecular characterization and dissociation mechanisms of PROTACs targeting hFAAH.

Physical chemistry chemical physics : PCCP·2026
Same author

A longitudinal study on the effect of aerobic exercise intervention on working memory of college students with internet addiction.

Scientific reports·2026
Same author

An MRI-based radiomics model for precision subtyping of hereditary spastic paraplegia: discriminating SPG4 from SPG5.

Neuroradiology·2026

Related Experiment Video

Updated: Jul 17, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.2K

Research Progress on hCNT3 Structure/Function and Nucleoside Anticancer Drugs.

Xinru Yue1, Xun Zhang1, Derong Zhang2

  • 1Sichuan Provincial Education Department Key Laboratory of Medicinal and Edible Plant Resources Development, College of Pharmacy, Chengdu University, Chengdu, China.

Current Protein & Peptide Science
|September 6, 2023
PubMed
Summary
This summary is machine-generated.

Human concentrative nucleoside transporter 3 (hCNT3) delivers nucleoside anticancer drugs to target sites. Understanding hCNT3

Keywords:
Na+-couplingTM9.hCNT3molecular designnucleoside deliverysubstrate recognition

More Related Videos

Nucleoside Triphosphates - From Synthesis to Biochemical Characterization
15:22

Nucleoside Triphosphates - From Synthesis to Biochemical Characterization

Published on: April 3, 2014

17.1K
Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
08:33

Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors

Published on: January 19, 2015

9.0K

Related Experiment Videos

Last Updated: Jul 17, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.2K
Nucleoside Triphosphates - From Synthesis to Biochemical Characterization
15:22

Nucleoside Triphosphates - From Synthesis to Biochemical Characterization

Published on: April 3, 2014

17.1K
Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
08:33

Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors

Published on: January 19, 2015

9.0K

Area of Science:

  • Membrane protein structure and function
  • Pharmacology and drug delivery
  • Molecular evolution and conservation

Background:

  • Human concentrative nucleoside transporter 3 (hCNT3) facilitates nucleoside and nucleoside-analog anticancer drug uptake.
  • hCNT3 plays a crucial role in delivering therapeutic agents to disease sites.
  • Its structural and functional characteristics are vital for drug development.

Purpose of the Study:

  • To review the sequence evolution, conservation, and molecular structure of hCNT3.
  • To summarize hCNT3's substrate recognition, transport mechanism, and interaction with nucleoside derivative drugs.
  • To provide theoretical guidance for designing novel hCNT3-targeting anticancer drugs.

Main Methods:

  • Review of existing literature on hCNT3.
  • Analysis of sequence evolution and conservation data.
  • Examination of structural and functional studies of hCNT3 and homologous transporters.

Main Results:

  • hCNT3 exhibits high conservation across vertebrates and possesses distinct scaffold and transport domains.
  • The transporter utilizes an elevator-like motion involving transmembrane helices and hairpin loops for substrate translocation.
  • hCNT3 recognizes and transports various nucleoside-derived anticancer drugs, including fludarabine, cladribine, decitabine, and clofarabine.

Conclusions:

  • hCNT3's structural and functional properties are key to its role in nucleoside analog drug delivery.
  • Understanding hCNT3's transport mechanism and substrate specificity can inform the design of more effective anticancer therapies.
  • Further research into hCNT3 is essential for developing targeted drug delivery strategies.